Richard Kuntz Dia Medica Therapeutics Inc. (DMAC) insider trading activity

DMAC Quotes by TradingView

Richard Kuntz is Director of DiaMedica Therapeutics Inc.. Currently has a direct ownership of 14,285 shares of DMAC, which is worth approximately $57,568. The most recent transaction as insider was on Jan 02, 2024, when has been sold 14,285 shares (Voting Common Shares, no par value per share) at a price of $2.8 per share, resulting in proceeds of $39,998. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14.3K
0% 3M change
n/a 12M change
Total Value Held $57,568

Richard Kuntz Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 02 2024
BUY
Grant, award, or other acquisition
$39,998 $2.8 p/Share
14,285 Added 50.0%
14,285 Voting Common Shares, ...

Also insider at

MDT
Medtronic plc Healthcare
SVP & Chief Medical & Science
ZIMV
ZimVie Inc. Healthcare
Director
RKLY
Rockley Photonics Holdings Ltd Technology
Director
INVE
Identiv, Inc. Technology
RK

Richard Kuntz

Director
Minneapolis, MN

Track Institutional and Insider Activities on DMAC

Follow DiaMedica Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DMAC shares.

Notify only if

Insider Trading

Get notified when an Dia Medica Therapeutics Inc. insider buys or sells DMAC shares.

Notify only if

News

Receive news related to DiaMedica Therapeutics Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on DMAC